New Horizon Health Limited
New Horizon Health Limited (6606.HK) Stock Competitors & Peer Comparison
See (6606.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6606.HK | HK$14.14 | +0.00% | 6.3B | 58.92 | HK$0.24 | N/A |
| 2252.HK | HK$27.56 | +7.24% | 25.9B | -46.74 | -HK$0.54 | N/A |
| 0853.HK | HK$9.52 | -3.15% | 17.5B | -12.99 | -HK$0.73 | N/A |
| 1858.HK | HK$13.83 | +10.29% | 7.8B | 27.31 | HK$0.48 | +2.17% |
| 2190.HK | HK$24.12 | +1.26% | 7.4B | 27.02 | HK$0.86 | +0.47% |
| 1302.HK | HK$1.81 | +2.84% | 7.4B | 84.00 | HK$0.02 | N/A |
| 1789.HK | HK$6.34 | +2.59% | 6.9B | 18.18 | HK$0.34 | +1.17% |
| 1763.HK | HK$20.38 | +1.19% | 6.4B | 13.19 | HK$1.51 | +2.14% |
| 2172.HK | HK$10.97 | +2.52% | 6.1B | 29.22 | HK$0.36 | +1.52% |
| 6669.HK | HK$13.00 | +0.00% | 3.8B | 29.14 | HK$0.44 | N/A |
Stock Comparison
6606.HK vs 2252.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2252.HK has a market cap of 25.9B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2252.HK trades at HK$27.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2252.HK's P/E ratio is -46.74. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2252.HK's ROE of -0.52%. Regarding short-term risk, 6606.HK is more volatile compared to 2252.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2252.HK's competition here
6606.HK vs 0853.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 0853.HK has a market cap of 17.5B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 0853.HK trades at HK$9.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 0853.HK's P/E ratio is -12.99. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 0853.HK's ROE of -0.27%. Regarding short-term risk, 6606.HK is more volatile compared to 0853.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 0853.HK's competition here
6606.HK vs 1858.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 1858.HK has a market cap of 7.8B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 1858.HK trades at HK$13.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 1858.HK's P/E ratio is 27.31. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 1858.HK's ROE of +0.09%. Regarding short-term risk, 6606.HK is more volatile compared to 1858.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 1858.HK's competition here
6606.HK vs 2190.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2190.HK has a market cap of 7.4B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2190.HK trades at HK$24.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2190.HK's P/E ratio is 27.02. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2190.HK's ROE of +0.08%. Regarding short-term risk, 6606.HK is more volatile compared to 2190.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2190.HK's competition here
6606.HK vs 1302.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 1302.HK has a market cap of 7.4B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 1302.HK trades at HK$1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 1302.HK's P/E ratio is 84.00. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 1302.HK's ROE of +0.02%. Regarding short-term risk, 6606.HK is more volatile compared to 1302.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 1302.HK's competition here
6606.HK vs 1789.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 1789.HK has a market cap of 6.9B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 1789.HK trades at HK$6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 1789.HK's P/E ratio is 18.18. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 1789.HK's ROE of +0.12%. Regarding short-term risk, 6606.HK is more volatile compared to 1789.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 1789.HK's competition here
6606.HK vs 1763.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 1763.HK has a market cap of 6.4B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 1763.HK trades at HK$20.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 1763.HK's P/E ratio is 13.19. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 1763.HK's ROE of +0.08%. Regarding short-term risk, 6606.HK is more volatile compared to 1763.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 1763.HK's competition here
6606.HK vs 2172.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2172.HK has a market cap of 6.1B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2172.HK trades at HK$10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2172.HK's P/E ratio is 29.22. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2172.HK's ROE of +0.10%. Regarding short-term risk, 6606.HK is more volatile compared to 2172.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2172.HK's competition here
6606.HK vs 6669.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 6669.HK has a market cap of 3.8B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 6669.HK trades at HK$13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 6669.HK's P/E ratio is 29.14. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 6669.HK's ROE of +0.07%. Regarding short-term risk, 6606.HK is more volatile compared to 6669.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 6669.HK's competition here
6606.HK vs 9996.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 9996.HK has a market cap of 3.8B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 9996.HK trades at HK$6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 9996.HK's P/E ratio is -16.23. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 9996.HK's ROE of -0.11%. Regarding short-term risk, 6606.HK is more volatile compared to 9996.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 9996.HK's competition here
6606.HK vs 2235.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2235.HK has a market cap of 3.1B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2235.HK trades at HK$7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2235.HK's P/E ratio is -104.14. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2235.HK's ROE of -0.01%. Regarding short-term risk, 6606.HK is more volatile compared to 2235.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2235.HK's competition here
6606.HK vs 6609.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 6609.HK has a market cap of 1.7B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 6609.HK trades at HK$48.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 6609.HK's P/E ratio is 18.59. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 6609.HK's ROE of +0.04%. Regarding short-term risk, 6606.HK is more volatile compared to 6609.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 6609.HK's competition here
6606.HK vs 1696.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 1696.HK has a market cap of 1.5B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 1696.HK trades at HK$3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 1696.HK's P/E ratio is 10.22. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 1696.HK's ROE of +0.04%. Regarding short-term risk, 6606.HK is more volatile compared to 1696.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 1696.HK's competition here
6606.HK vs 2160.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2160.HK has a market cap of 1.3B. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2160.HK trades at HK$2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2160.HK's P/E ratio is 135.00. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2160.HK's ROE of +0.00%. Regarding short-term risk, 6606.HK is more volatile compared to 2160.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2160.HK's competition here
6606.HK vs 2500.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2500.HK has a market cap of 810.1M. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2500.HK trades at HK$2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2500.HK's P/E ratio is -1.11. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2500.HK's ROE of -0.30%. Regarding short-term risk, 6606.HK is more volatile compared to 2500.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2500.HK's competition here
6606.HK vs 2407.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2407.HK has a market cap of 786.8M. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2407.HK trades at HK$5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2407.HK's P/E ratio is 7.09. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2407.HK's ROE of +0.06%. Regarding short-term risk, 6606.HK is more volatile compared to 2407.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2407.HK's competition here
6606.HK vs 2216.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2216.HK has a market cap of 647.5M. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2216.HK trades at HK$1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2216.HK's P/E ratio is -5.35. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2216.HK's ROE of -0.09%. Regarding short-term risk, 6606.HK is less volatile compared to 2216.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 6606.HK.Check 2216.HK's competition here
6606.HK vs 1612.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 1612.HK has a market cap of 590.8M. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 1612.HK trades at HK$0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 1612.HK's P/E ratio is 5.69. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 1612.HK's ROE of +0.16%. Regarding short-term risk, 6606.HK is more volatile compared to 1612.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 1612.HK's competition here
6606.HK vs 2170.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2170.HK has a market cap of 530.7M. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2170.HK trades at HK$2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2170.HK's P/E ratio is -1.90. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2170.HK's ROE of -0.22%. Regarding short-term risk, 6606.HK is more volatile compared to 2170.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2170.HK's competition here
6606.HK vs 6118.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 6118.HK has a market cap of 420.3M. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 6118.HK trades at HK$0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 6118.HK's P/E ratio is 10.25. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 6118.HK's ROE of +0.04%. Regarding short-term risk, 6606.HK is more volatile compared to 6118.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 6118.HK's competition here
6606.HK vs 2297.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2297.HK has a market cap of 378.4M. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2297.HK trades at HK$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2297.HK's P/E ratio is -2.70. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2297.HK's ROE of -0.26%. Regarding short-term risk, 6606.HK is more volatile compared to 2297.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2297.HK's competition here
6606.HK vs 2393.HK Comparison April 2026
6606.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6606.HK stands at 6.3B. In comparison, 2393.HK has a market cap of 228.5M. Regarding current trading prices, 6606.HK is priced at HK$14.14, while 2393.HK trades at HK$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6606.HK currently has a P/E ratio of 58.92, whereas 2393.HK's P/E ratio is -1.23. In terms of profitability, 6606.HK's ROE is -0.04%, compared to 2393.HK's ROE of -0.35%. Regarding short-term risk, 6606.HK is more volatile compared to 2393.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6606.HK.Check 2393.HK's competition here